CLOVERNA is a biopharmaceutical company specializing in RNA targeted drug discovery. The company's unique platform is centered around a novel RNA-targeted Drug Discovery technology, which identifies new RNA databases and drug candidates to address rare diseases, offering renewed hope to patients. Founded in 2020, CLOVERNA is committed to uncovering previously unavailable biology and revolutionizing medicine. With a focus on Biopharma, Biotechnology, and Pharmaceutical industries, the company is dedicated to discovering groundbreaking medicines. Although specific information regarding headquarter location and recent investments is not available, CLOVERNA is poised to make a significant impact in the biopharmaceutical sector.
There is no investment information
No recent news or press coverage available for CLOVERNA.